Matricaria chamomilla extract inhibits both development of morphine dependence and expression of abstinence syndrome in rats

Journal Pharmacological Sciences

Volumn 92, Issue 1, 2003, Pages 50-55

  Gomaa, Adel ^a   Hashem, Tahia ^a   Mohamed, Mahmoud ^a   Ashry, Esraa ^a  

^a Assiut University Faculty of Medicine   (Egypt)

Author keywords

Matricaria chamomilla extract; Morphine dependence; Plasma cAMP; Withdrawal manifestation

Indexed keywords

CYCLIC AMP; MATRICARIA CHAMOMILLA EXTRACT; MORPHINE; MORPHINE DERIVATIVE; NALOXONE; NARCOTIC AGENT; NARCOTIC ANTAGONIST; PLANT EXTRACT; SODIUM CHLORIDE;

ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR DISORDER; BLOOD; CHEMISTRY; COMPARATIVE STUDY; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; MALE; MATRICARIA; MICTURITION; MORPHINE ADDICTION; NONHUMAN; PROTEIN BLOOD LEVEL; PTOSIS; RAT; RAT STRAIN; SINGLE DRUG DOSE; TREMOR; WEIGHT REDUCTION; WITHDRAWAL SYNDROME;

MATRICARIA CHAMOMILLA;

EID: 0037704157     PISSN: 13478613     EISSN: None     Source Type: Journal    
DOI: 10.1254/jphs.92.50     Document Type: Article

References (34)

1. Johnson SM, Fleming WW. Mechanisms of cellular adaptive sensitivity changes: Application to opioid tolerance and dependence. Pharmacol Rev. 1989;41:435-487.
2. Mamiya T, Noda Y, Ren X, et al. Involvement of cyclic AMP systems in morphine physical dependence in mice: Prevention of development of morphine dependence by rolipram, a phosphodiestrase 4 inhibitors. Br J Pharmacol. 2001;32:1111-1117.
3. Chang KJ, Hazum E, Killian A, Cuatrecasas P. Interaction of ligand with morphine and enkephalin receptors is differentially affected by guanine nucleotides. Mol Pharmacol. 1981;20:1-7.
4. Griffin MT, Law PY, Loh HH. Involvement of the brain inhibitory and stimulating guanine nucleotide binding proteins in the expression of chronic opiate regulation of adenylate cyclase activity in NG 108-15 cells. J Neurochem. 1985;45:1585-1589.
5. Thompson WJ. Cyclic nucleotide phosphodiestrase: Pharmacology, biochemistry and function. Pharmacol Ther. 1991;51:13-33.
6. Itoh A, Shiotani T, Nakayama S, et al. Attenuation of the development of morphine dependence/tolerance by nefiracetam: Involvement of adenosine 3′:5′ cyclic monophosphate system. Behav Brain Res. 2000;115:65-74.
7. Itoh A, Noda Y, Mamiya T, Hasegawa T, Nabeshima TA. Therapeutic strategy to prevent morphine dependence of a cAMP-related reagents with morphine. Methods Find Exp Clin Pharmacol. 1998;20:619-625.
8. Wang Z, Bilsky EJ, Wang D, Porreca F, Sadee W. 3-Isobutyl-1-methylxanthine inhibits basal mu-opioid receptors phosphorylation and reverse acute morphine tolerance and dependence in mice. Eur J Pharmacol. 1999;23:1-9.
9. Hamdy M, Mamia T, Noda Y, et al. Selective phosphodiestrase IV inhibitor, rolipram blocks both withdrawal behavioral manifestations, and c-Fos protein expression in morphine dependent mice. Behav Brain Res. 2001;118:85-93.
10. Sribanditmongkol P, Shue MI, Tejwani GA. Inhibition of morphine tolerance and dependence by diazepam and its relation to the CNS met-enkephalin levels. Brain Res. 1994;645:1-12.
11. Tejwani GA, Sribanditmongkol P, Sheu MJ. Inhibition of morphine tolerance and dependence by diazepam. Regul Pept. 1994;50:S207-S208.
12. Sheu MJ, Sribanditmongkol P, Santosa D, Tejwani GA. Inhibition of morphine tolerance and dependence by diazepam and its relation to cyclic AMP levels in discrete rat brain regions and spinal cord. Brain Res. 1995;675:31-37.
13. Leung AY, Foster S. Matricaria chamomilla. In: Encyclopedia of Common Natural Ingredients. 2nd. New York: A. Wiley-Interscience Publication; 1998. p. 164A.
14. Viola H, Wasowki C, Levi De Stein M, et al. Apigenin, a component of Matricaria recuitta flowers, is a central benzodiazepine receptors-ligand with anxiolytic effects. Planta Med. 1995;61:213-216.
15. Avallone R, Zanoli P, Corsil L, Cannazza G, Baraldi M. Benzodiazepine-like compounds and GABA in flower head of Matricaria chamomilla. Phytother Res. 1996;10:s177-s179.
16. Ferrel JE, Chang Sing PDG, Leow G, King R, Mansour JM, Mansour TE. Structure-activity studies of flavonoids as inhibitors of cyclic AMP phosphodiesterase and relationship to quantum chemical indices. Mol Pharmacol. 1979;16:556-568.
17. Ruckstuhl M, Beretz A, Anton R, Landry Y. Flavonoids are selective cyclic GMP phosphodiesterase inhibitors. Biochem Pharmacol. 1979;28:535-538.
18. Beretz A, Anton R, Cazenove J. The effects of flavonoid on cyclic nucleotide phosphodiesterase. In: Cody V, Middleton EJ, Harbone B, editors. Plant Flavonoids in Biology and Medicine. Biochemical Pharmacological and Structure-Activity Relationship. New York: Alan R Liss; 1986. p. 281-296.
19. Kuppusamy UR, Das NP. Effects of flavonoids on lipid mobilization in rat adipocytes. Biochem Pharmacol. 1992;44:1307-1315.
20. Gerritsen ME, Carley WW, Ranges GE, et al. Flavonoids inhibit cytokine-induced endothelial cell adhesion protein gene expression. Am J Pathol. 1995;147:278-292.
21. Kuo ML, Yang NC. Reversion of v-H-ras-transformed NIH 3T3 cells by apigenin through inhibiting mitogen activated protein kinase and its downstream oncogenes. Biochem Biophys Res Commun. 1995;26:267-275.
22. Rekka EA, Kourounakis AP, Kourounakis PN. Investigation of the effect of chamazulene on lipid peroxidation and free radical processes. Res Commun Mol Pathol Pharmacol. 1996;92:361-364.
23. Liang YC, Huang YT, Tsai SH, Lin-Shiau SY, Chen CF, Lin JK. Suppression of inducible cyclo oxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages. Carcinogenesis. 1999;20:1945-1952.
24. Capasso A, Piacente S, Pizza C, Sorrentino L. Flavonoids reduce morphine withdrawal in-vitro. J Pharm Pharmacol. 1998;50:561-564.
25. Nakaki T, Muraki T, Tokunaga Y, Kato R. Plasma cyclic AMP in the morphine-tolerant rat. Biochem Pharmacol. 1981;30:2217-2220.
26. Romandini S, Cervo L, Samanin R. Evidence that drugs increasing 5-hydroxytryptamine transmission block jumping but not dog shakes in morphine-abstinent rats: A comparison with clonidine. J Pharm Pharmacol. 1984;36:68-70.
27. Mucsi I, Pragai BM. Inhibition of virus multiplication and alteration of cyclic AMP level in cell cultures by flavonoids. Experientia. 1985;41:930-935.
28. Revuelta MP, Hidalgo A, Cantabrana B. Involvement of cAMP and beta-adrenoceptors in the relaxing effect elicited by flavonoids on rat uterine smooth muscle. J Auton Pharmacol. 1999;19:353-358.
29. Nabeshima T, Noda Y, Itoh A, Mamiya T. Prevention of development of dependence to morphine by using cyclic AMP-related compounds in mice. In: Okada Y, editor. The Role of Adenosine in the Nervous System. Tokyo: Elsevier; p. 251-257.
30. Blendy JA, Maldonado R. Genetic analysis of drug addiction: The role of cAMP response element binding protein. J Mol Med. 1998;76:104-110.
31. Harris GC, Williams JT. Transient homologous μ-opioid receptor desensitization in rat locus coeruleus neurons. J Neurochem. 1991;11:2574-2581.
32. Nestler EJ, Bruce TH, Katherine LW. Drug addiction: A model for the molecular basis of neural plasticity. Neuron. 1993;11:995-1006.
33. Salgueiro JB, Ardenghi P, Dias M, Ferreia MB, Izquierdo I, Medina JH. Anxiolytic natural and synthetic flavonoid ligands of the central benzodiazepine receptor have no effect on memory tasks in rats. Pharmacol Biochem Behav. 1997;58:887-891.
34. Avallone R, Zanoli P, Puia G, Kleinschnitz M, Schreier P, Baraldi M. Pharmacological profile of apigenin, a flavonoid isolated from Matricaria chamomilla. Biochem Pharmacol. 2000;59:1387-1394.